drugset / Trial / NCT00021268

Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer

NCT00021268 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of tocladesine in treating patients who have recurrent or progressive metastatic colorectal cancer.

Timeline

Start
2001-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject tocladesine Small molecule — Intravenous

Indications